10x Genomics Inc (NAS:TXG)
$ 24.83 -0.18 (-0.72%) Market Cap: 2.97 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

Q4 2020 10X Genomics Inc Earnings Call Transcript

Feb 17, 2021 / 09:30PM GMT
Release Date Price: $187.55 (-2.54%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the 10x Genomics Fourth Quarter 2020 Earnings Conference Call. (Operator Instructions) I would now like to hand the call over to your speaker today, Ms. Cassie Corneau, Investor Relations and Strategic Finance. Please go ahead.

Cassie Corneau
10x Genomics, Inc. - Manager, IR & Strategic Finance

Thank you. Good afternoon, everyone. Earlier today, 10x Genomics released financial results for the fourth quarter and year ended December 31, 2020. If you have not received this news release or if you would like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot